相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behcet's disease
Luca Cantarini et al.
AUTOIMMUNITY REVIEWS (2015)
Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
Linda Rossi-Semerano et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Anakinra treatment in patients with gout and type 2 diabetes
Antonio Vitale et al.
CLINICAL RHEUMATOLOGY (2015)
FRI0219 Disease severity, no steroid use and type ii diabetes predict response to anakinra (kineret®) in patients with rheumatoid arthritis
B. Missler-Karger et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
Rebeccah J. Mathews et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
Susana Vallejo et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis
Ignatios Ikonomidis et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2014)
Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity
H. Brauner et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Caspases and inflammasomes in metabolic inflammation
Alexander M. Skeldon et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Interleukin-1 Receptor Antagonist Originating from Bone Marrow-derived Cells and Non-bone Marrow-derived Cells Helps to Suppress Arterial Inflammation and Reduce Neointimal Formation after Injury
Kikuo Isoda et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
Ernest Choy et al.
RHEUMATOLOGY (2014)
Cardiovascular Comorbidity in Rheumatic Diseases A Focus on Heart Failure
Kerry Wright et al.
HEART FAILURE CLINICS (2014)
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Iciar Martin-Timon et al.
WORLD JOURNAL OF DIABETES (2014)
CD4+CD45RA-FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes
F. Haseda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Hye-Mi Lee et al.
DIABETES (2013)
Macrophages and islet inflammation in type 2 diabetes
K. Eguchi et al.
DIABETES OBESITY & METABOLISM (2013)
Macrophages control innate inflammation
S. Akira et al.
DIABETES OBESITY & METABOLISM (2013)
L-Cysteine and Hydrogen Sulfide Increase PIP3 and AMPK/PPARγ Expression and Decrease ROS and Vascular Inflammation Markers in High Glucose Treated Human U937 Monocytes
Prasenjit Manna et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
Katherine P. Liao et al.
RHEUMATOLOGY (2013)
Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
A. Cas et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2013)
Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
Ryan W. Grant et al.
FRONTIERS IN IMMUNOLOGY (2013)
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
Juan Antonio Avina-Zubieta et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen A Phase IIb Randomized, Placebo-Controlled Trial
Paul M. Ridker et al.
CIRCULATION (2012)
The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study
Aamer Sandoo et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
AMERICAN HEART JOURNAL (2011)
Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
Ashley M. Miller et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
Yun-Hee Youm et al.
ENDOCRINOLOGY (2011)
Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis
Jean-Frederic Boyer et al.
JOINT BONE SPINE (2011)
Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Edwin J. P. van Asseldonk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inflammasome is a central player in the induction of obesity and insulin resistance
Rinke Stienstra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Diabetes Mellitus and Insulin Resistance in Patients With Rheumatoid Arthritis: Risk Reduction in a Chronic Inflammatory Disease
Mary Chester Wasko et al.
ARTHRITIS CARE & RESEARCH (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Inflammation and Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Effect of Treatment
Will Foster et al.
JOURNAL OF RHEUMATOLOGY (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Kate Schroder et al.
SCIENCE (2010)
Inflammatory Mediators and Premature Coronary Atherosclerosis in Rheumatoid Arthritis
Young Hee Rho et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Rheumatoid Arthritis - A Model of Systemic Inflammation Driving Atherosclerosis
Ivy A. Ku et al.
CIRCULATION JOURNAL (2009)
Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes
Christian Herder et al.
DIABETES CARE (2009)
Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
Claus M. Larsen et al.
DIABETES CARE (2009)
Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis
I. Ikonomidis et al.
HEART (2009)
Role of inflammation in atherosclerosis associated with rheumatoid arthritis
Peter Libby
AMERICAN JOURNAL OF MEDICINE (2008)
Cardiovascular morbidity and mortality in rheumatoid arthritis
Sherine E. Gabriel
AMERICAN JOURNAL OF MEDICINE (2008)
Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
J. Antonio Avina-Zubieta et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis
Ignatios Ikonomidis et al.
CIRCULATION (2008)
The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia
Nadine S. Sauter et al.
ENDOCRINOLOGY (2008)
TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis
Silvia Bosello et al.
CLINICAL RHEUMATOLOGY (2008)
Increased number of islet-associated macrophages in type 2 diabetes
Jan A. Ehses et al.
DIABETES (2007)
High glucose induces IL-1β expression in human monocytes:: mechanistic insights
Mohan R. Dasu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The Fas pathway is involved in pancreatic β cell secretory function
Desiree M. Schumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Glucose ingestion induces an increase in intranuclear nuclear factor κB, a fall in cellular inhibitor κB, and an increase in tumor necrosis factor α messenger RNA by mononuclear cells in healthy human subjects
Ahmad Aljada et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Effects of etanercept in patients with the metabolic syndrome
LE Bernstein et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
T Wæhre et al.
CIRCULATION (2004)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with Infliximab
P Di Rocco et al.
OBESITY RESEARCH (2004)
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor α antibody
C Gonzalez-Juanatey et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity
S Hänsel et al.
ATHEROSCLEROSIS (2003)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells
N Shanmugam et al.
DIABETES (2003)
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
DH Solomon et al.
CIRCULATION (2003)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
JMM Evans et al.
BRITISH MEDICAL JOURNAL (2002)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways
M Guha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
